Results - Announcements
JHS Svendgaard Laboratories Ltd share price remained flat to Rs 8.07 after the company's net profit plunged by 53.21% to Rs 0.51 crore, while revenue from operations dropped sharply 28.14% to Rs 21.83 crore in Q3FY26 over Q2FY26.
The market capitalization of Personal Care industry group stocks on BSE stood at Rs 3.65 lakh crore, improving 12.25%. It has improved by 2.74% over last one week and fell by 10.63% in last one month while the market capitalization of JHS Svendgaard Laboratories Ltd has softened by 1.93% and 3.60% in the same period respectively.
Profit before tax (PBT) of JHS Svendgaard Laboratories Ltd stood at Rs 0.4 crore in Q3 FY26, expanding by 1900.00% year-on-year, and crashing by 766.67% quarter-on-quarter. EBITDA came in at Rs 1 crore, surging by 217.39% YoY and tanking 136.68% sequentially.
Total expenses slumped by 23.20% to Rs 23.14 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 13.68 crore, slumping by 26.96% YoY, while employee benefits expense was at Rs 2.96 crore, ticking higher by 3.14% YoY.
For the TTM ended FY26, revenue from operations improved 10.53% to Rs 101.69 crore, while net profit tanked by 90.27% to Rs 1.92 crore, compared to previous TTM. EBITDA saw a sharp decline of 834% to Rs 0.83 crore, and PBT collapsed by 81.69% to Rs 2.29 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 2.66 crore in FY26, as against Rs 5.18 crore in FY25.
JHS Svendgaard Laboratories Ltd nosedived by 37.44% in last one year, underperforming the benchmark BSE Sensex which has slipped by 9.87% during the same period.